- Home
- REE vs CRVO Comparison
REE vs CRVO Comparison
Compare REE & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- CRVO
- Stock Information
- Founded
- REE 2011
- CRVO 2001
- Country
- REE Israel
- CRVO United States
- Employees
- REE N/A
- CRVO N/A
- Industry
- REE Auto Manufacturing
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- CRVO Health Care
- Exchange
- REE Nasdaq
- CRVO Nasdaq
- Market Cap
- REE 77.3M
- CRVO 69.3M
- IPO Year
- REE N/A
- CRVO N/A
- Fundamental
- Price
- REE $0.78
- CRVO $8.16
- Analyst Decision
- REE Strong Buy
- CRVO Strong Buy
- Analyst Count
- REE 2
- CRVO 8
- Target Price
- REE $11.75
- CRVO $25.57
- AVG Volume (30 Days)
- REE 705.8K
- CRVO 209.3K
- Earning Date
- REE 05-15-2025
- CRVO 05-12-2025
- Dividend Yield
- REE N/A
- CRVO N/A
- EPS Growth
- REE N/A
- CRVO N/A
- EPS
- REE N/A
- CRVO N/A
- Revenue
- REE $183,000.00
- CRVO $9,308,215.00
- Revenue This Year
- REE $18,412.57
- CRVO N/A
- Revenue Next Year
- REE $938.14
- CRVO N/A
- P/E Ratio
- REE N/A
- CRVO N/A
- Revenue Growth
- REE N/A
- CRVO 15.14
- 52 Week Low
- REE $0.71
- CRVO $1.80
- 52 Week High
- REE $11.72
- CRVO $22.57
- Technical
- Relative Strength Index (RSI)
- REE 25.41
- CRVO 46.68
- Support Level
- REE $0.75
- CRVO $7.01
- Resistance Level
- REE $0.83
- CRVO $8.59
- Average True Range (ATR)
- REE 0.23
- CRVO 0.55
- MACD
- REE -0.03
- CRVO -0.12
- Stochastic Oscillator
- REE 2.30
- CRVO 55.56
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is developing REEcorner technology which packs critical vehicle components into a single compact module positioned between the chassis and the wheel as well as building commercial Electric Vehicles (EV) leveraging REEcorner technology. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.